IMS Company Profiles - Report Buyer

IMS COM PANY PRO FILES TAKEDA SUBSIDIARY LISTING
NONFLAMIN (an al ge sic non-nar cotic)
PROSOGAN FD (antiulcerant)
NICHOLIN (ce re bral/pe riph eral vasotherapeutic)
Ther a peu tic Range:
vi ta mins 29%
renin-an gio ten sin sys tem agents 16%
an al ge sics 11%
ant ac ids/antiflatulents/antiulcerants 9%
antibacterials sys temic 8%
Lead ing Dose Forms:
tab lets 62%
am poules 12%
cap sules 11%
vi als 10%
sup pos i to ries 3%
� IRELAND
TAKEDA
Full Name: Takeda Ire land Ltd
Street Ad dress: Bray Busi ness Park, Kilruddery
Co Wicklow
Tel: +353 1 2050600
Fax: +353 1 2050601
Home Page: www.takeda.ie
De scrip tion: De vel oper, man u fac turer, for mu la -
tor, packager/as sem bler, ex porter. Man u fac tures
for other com pa nies. Prod uct ranges in clude:
phar ma ceu ti cal prod ucts (branded, pre scrip tion).
Es tab lished 1997. 420 phar ma ceu ti cal employees
in 2007.
Rep re sen ta tives/De tail ers (Pharm, Num -
ber): 0 (2007)
Con tacts (Pharm): Man u fac ture: Paul Blunnie;
Gen eral Con tact: Tony Grannell
Sub sid iary of: Takeda, Ja pan (100%)
TAKEDA PHARMA
Full Name: Takeda Pharma Ire land Lim ited (TPI)
Street Ad dress: Grange Cas tle Busi ness Park,
Dub lin 22
Tel: +353 1 4672400
Fax: +353 1 4672401
Email: tpiinfo@takeda.ie
Home Page: www.takeda.ie
De scrip tion: Man u fac turer. Prod uct ranges in -
clude: phar ma ceu ti cal prod ucts (branded, pre -
scrip tion), fine chem i cals. Es tab lished 2002. 50
phar ma ceu ti cal employees in 2006.
Rep re sen ta tives/De tail ers (Pharm, Num -
ber): 0 (2006)
Con tacts (Pharm): Chair man: Yoshiharu Maeda
Sub sid iary of: Takeda, Ja pan (100%)
� ITALY
TAKEDA
Full Name: Takeda Italia Farmaceutici SpA
Street Ad dress: Via Elio Vittorini, 129, 00144
Roma
Tel: +39 06 502601
Fax: +39 06 5011709
De scrip tion: Re searcher, de vel oper, man u fac -
turer, im porter, dis trib u tor, pro moter,
sales/detailer, packager/as sem bler. Prod uct
ranges in clude: phar ma ceu ti cal prod ucts
(branded, pre scrip tion). Es tab lished 1982. 664
phar ma ceu ti cal employees in 2007.
Rep re sen ta tives/De tail ers (Pharm, Num -
ber): 101-500 (2007)
Con tacts (Pharm): Chair man: Dr S. Maurizio
Castorina; Com mer cial Op er a tions: Dr Paolo La
Commare; Man u fac ture: Dr Pierfelice Ferrari;
Mar ket Re search: Dr Arnaldo Scarrone; Re search
& De vel op ment: Dr Cinzia Di Pietro; Gen eral Con -
tact: Ornella Gallo
Sub sid iary of: Takeda, Neth er lands (76.92%)
Phar ma ceu ti cal Sales: US$ 270-280 mil lion
Prod ucts (% of Sales by Lead ing 5): 85-90%
Ther a peu tic Classes (% of Sales by Lead ing
5): 95-100%
Dose Forms (% of Sales by Lead ing 5):
95-100%
Prin ci pal Prod ucts:
LANSOX (antiulcerant)
BLOPRESS (an gio ten sin-II an tag o nist plain)
BLOPRESID (an gio ten sin-II an tag o nist com bi na -
tion)
ENANTONE DE POT (cytostatic hor mone)
ACTOS (antidiabetic oral)
Ther a peu tic Range:
renin-an gio ten sin sys tem agents 36%
ant ac ids/antiflatulents/antiulcerants 32%
cytostatic hor mone ther apy 14%
drugs used in di a be tes 10%
cal cium an tag o nists 5%
Lead ing Dose Forms:
tab lets 57%
cap sules 24%
vi als 14%
coated tab lets 5%
pow ders/gran ules -
© 2009 IMS Health In cor po rated or its af fil i ates Page 125